018401619

ZELRAYMI

---

February 16, 2021

Trademark Summary

The trademark application ZELRAYMI was filed by Genzyme Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on March 29, 2021, and it was registered by office on July 6, 2021 without any oppositions.

The application was filed in English (French was selected as the second language).

Change of name and professional address of the trademark registration was recorded on February 1, 2022. Change of name and address of the trademark registration was recorded on August 16, 2022.

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system
  2. Pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases
  3. Pharmaceutical preparations for the treatment of rare diseases notably lysosomal storage disorders and autosomal dominant polycystic kidney disease
  4. Pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections.